“A Prospective Observational Study of Comparison, Safety, and Efficacy of Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus in A Tertiary Care Hospital” (2022) Asian Journal of Pharmaceutical and Health Sciences, 12(4), pp. 2729–2738. doi:10.5530/ezagjy22.